The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.EBI
F. Hoffmann-La Roche
 
Evaluation of (2S,4S)/(2R,4R) and (2S,4R)/(2<...EBI
TBA
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.EBI
Sigma Tau Pharmaceutical Industries
Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents.EBI
Sigma Tau Pharmaceutical Industries
(+)-Hemipalmitoylcarnitinium strongly inhibits carnitine palmitoyltransferase-I in intact mitochondria.EBI
Louisiana State University
Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors.EBI
Sandoz Research Institute
Resolution of (+/-)-2-tetradecyloxiranecarboxylic acid. Absolute configuration and chiral synthesis of the hypoglycemic R enantiomer and biological activity of enantiomers.EBI
TBA
(-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects.EBI
Yachaytech University